This pathway contributes to both the development and exacerbation of asthma by mediating the release of pro-inflammatory cytokines such as IL1β and IL18, which are critical in the pathogenesis of severe steroid-resistant asthma (SSRA) and other asthma phenotypes [148, 149]. The gene discussed is IL1B; the disease is asthma.